Table 1.
Clinicopathological characteristics of hepatocellular carcinoma patients n (%)
| Characteristics | Patients |
| Total | 213 (100) |
| Age (yr)a | |
| < 49 | 105 (49.3) |
| ≥ 49 | 108 (50.7) |
| Sex | |
| Female | 17 (8.0) |
| Male | 196 (92.0) |
| Grade | |
| I | 19 (8.9) |
| II | 97 (45.5) |
| III | 91 (42.7) |
| IV | 6 (2.8) |
| Stage | |
| I + II | 174 (81.7) |
| III + IV | 39 (18.3) |
| Relapse | |
| No | 83 (39.0) |
| Yes | 130 (61.0) |
| AFP (ng/mL) | |
| < 400 | 125 (58.7) |
| ≥ 400 | 88 (41.3) |
| Child-Pugh classification | |
| A | 195 (91.5) |
| B | 16 (7.5) |
| C | 2 (0.9) |
| HBV DNA | |
| Positive | 113 (53.1) |
| Negative | 100 (46.9) |
| Postoperative platelet count | |
| < 100 × 109/L | 35 (16.4) |
| ≥ 100 × 109/L | 178 (83.6) |
a
Median: 49, range: 25-75 years. AFP: Alpha fetoprotein; HBV: Hepatitis B virus.